Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Trading Statement

15 Jan 2025 07:00

RNS Number : 3050T
Galliford Try Holdings PLC
15 January 2025
Β 

Galliford Try Holdings plc

Trading Update

Wednesday 15 January 2025

Β 

Β 

Increased confidence in full year delivery

Β 

Β 

Galliford Try Holdings plc, the UK construction group, today provides an update on trading for the half year period from 1 July to 31 December 2024. The Group expects to announce its results for the half year on Wednesday 5 March 2025.

Β 

Update on Current Trading

Β 

The Group is performing well, winning a number of key projects and places on strategic frameworks throughout the first six months of the current financial year, and continues to make good progress against its Sustainable Growth Strategy to 2030.

Trading is ahead of both the prior year period and the Board's expectations. Given our continued project wins and improved framework participation, revenue and profit before tax for the full financial year are expected to be at the upper end of current market expectations1, reflecting continued progress towards our margin targets.

1 The range of analysts' forecasts for the year ended 30 June 2025, based on forecasts at 13 January 2025, is Β£1,803m to Β£1,835m for revenue and Β£34.0m to Β£35.4m for profit before tax.

Balance Sheet

Β 

The average month-end cash for the rolling 12 months ended 31 December 2024 was Β£176.4m (year to 30 June 2024: Β£154.8m) and period-end cash at 31 December 2024 was Β£210.0m (31 December 2023: Β£209.2m). The Group continues to maintain a portfolio of PPP assets and has no pensions liabilities and no bank debt or associated covenants. Β 

Β 

We believe the Group's strong balance sheet differentiates our ability to secure high quality contracts and frameworks, attract a highly skilled supply chain and continue to invest in the business whilst providing incremental returns to shareholders.

Β 

Capital Allocation

Β 

On 3 October 2024 the Group launched a share buyback programme of up to a maximum of Β£10.0m company shares. As at 13 January 2025 the Group had purchased a total of 1,389,432 shares, for an aggregate consideration of Β£5.1m.

Order Book and Outlook

Β 

The Group's order book of Β£3.9bn (31 December 2023: Β£3.7bn) remains predominantly in long term frameworks, including an excellent succession of wins in the in the water sector, providing visibility of secure future workload. We also see a good pipeline of opportunities across our chosen sectors, supported by our strong track record and focus on the public and regulated sectors alongside high-quality private clients.

Β 

Since the start of the financial year the Group's project and framework wins include:

Β 

- in Building appointed to build two projects in London with a combined value of Β£87m,

- in Highways appointed to build the Β£88.9m South East Aylesbury Link Road,

- in Environment we won places on the Β£3.7bn Wessex Water AMP8 Framework, the complex element of Yorkshire Water's Β£850m new Non-Infrastructure Works Framework and Southern Water's Capital Programme Strategic Delivery Partner Framework, and

- our Specialist Services businesses won places on the new Β£835m NHS North of England Commercial Procurement Collaborative.

Β 

Β 

Bill Hocking, Chief Executive, commented:

Β 

"Our strong performance in the first half of the financial year provides increased confidence for the full year.

Β 

We are pleased with our successes on the new AMP8 frameworks and the opportunities we see across all our chosen sectors. We have excellent people and project teams, a strong balance sheet and a high-quality carefully selected order book.Β 

Β 

Encouraged by our performance in the first six months of the year and the robust outlook, our expectations for the full year to June 2025 have improved accordingly."

Β 

Β 

For further enquiries please contact:

Β 

Galliford Try

Bill Hocking, Chief Executive

Kris Hampson, Chief Financial Officer

Kevin Corbett, General Counsel & Company Secretary

01895 855001

TeneoΒ 

James Macey White/Victoria Boxall

Β 

020 7353 4200

Β 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

Β 

Note to Editors

Galliford Try is a trading name of Galliford Try Holdings plc, a leadingΒ UKΒ construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure (environment and highways) projects with clients in the public, private and regulated sectors across the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBSGDBUUBDGUS
Date   Source Headline
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSContract
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 202512:00 pmRNSAnnual Financial Report
1st Oct 202510:00 amRNSTotal Voting Rights
30th Sep 20254:00 pmRNSHolding(s) in Company
29th Sep 20254:26 pmRNSDirector/PDMR Shareholding
26th Sep 20256:00 pmRNSFidelity European Trust
25th Sep 20253:57 pmRNSDirector/PDMR Shareholding - Replacement
25th Sep 20253:37 pmRNSDirector/PDMR Shareholding - Replacement
25th Sep 20253:00 pmRNSDirector/PDMR Shareholding
25th Sep 20253:00 pmRNSDirector/PDMR Shareholding
25th Sep 20253:00 pmRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20255:00 pmRNSHolding(s) in Company
18th Sep 20255:00 pmRNSHolding(s) in Company
17th Sep 20257:02 amRNSLaunch of Share Buyback Programme
17th Sep 20257:00 amRNSFinal Results
11th Sep 20255:00 pmRNSHolding(s) in Company
9th Sep 20254:15 pmRNSHolding(s) in Company
9th Sep 20253:05 pmRNSHolding(s) in Company
1st Sep 202510:00 amRNSTotal Voting Rights
28th Aug 20253:48 pmRNSHolding(s) in Company
26th Aug 20251:00 pmRNSBlock listing Interim Review
21st Aug 202510:15 amRNSContract
1st Aug 202510:00 amRNSTotal Voting Rights
9th Jul 20257:00 amRNSTrading Statement
1st Jul 20253:00 pmRNSHolding(s) in Company
30th Jun 20254:00 pmRNSTotal Voting Rights
18th Jun 20253:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSTotal Voting Rights
21st May 20257:10 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20254:00 pmRNSDirector/PDMR Shareholding
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
1st May 202510:00 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.